138 related articles for article (PubMed ID: 33567164)
21. Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature.
Fraenkel M; Kim M; Faggiano A; de Herder WW; Valk GD;
Endocr Relat Cancer; 2014 Jun; 21(3):R153-63. PubMed ID: 24322304
[TBL] [Abstract][Full Text] [Related]
22. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.
Hallet J; Law CH; Cukier M; Saskin R; Liu N; Singh S
Cancer; 2015 Feb; 121(4):589-97. PubMed ID: 25312765
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.
Guo LJ; Wang CH; Tang CW
Asia Pac J Clin Oncol; 2016 Sep; 12(3):284-8. PubMed ID: 27170574
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Clinical Prognostic Factors and Further Delineation of the Effect of Mesenteric Fibrosis on Survival in Advanced Midgut Neuroendocrine Tumours.
Laskaratos FM; Walker M; Wilkins D; Tuck A; Ramakrishnan S; Phillips E; Gertner J; Megapanou M; Papantoniou D; Shah R; Banks J; Vlachou E; Garcia-Hernandez J; Woodbridge L; Papadopoulou A; Grant L; Theocharidou E; Watkins J; Luong TV; Mandair D; Caplin M; Toumpanakis C
Neuroendocrinology; 2018; 107(3):292-304. PubMed ID: 30153671
[TBL] [Abstract][Full Text] [Related]
25. Management Strategies and Outcomes for Small Intestinal Neuroendocrine Tumours with Involvement of the Superior Mesenteric Vessels: A Systematic Review.
Kmiotek E; Lakda S; Borakati A; Ogunbiyi O; Mandair D; Caplin M; Toumpanakis C; Mirnezami R
Curr Oncol; 2023 Oct; 30(10):9192-9204. PubMed ID: 37887564
[TBL] [Abstract][Full Text] [Related]
26. Management of Small Bowel Neuroendocrine Tumors.
Scott AT; Howe JR
J Oncol Pract; 2018 Aug; 14(8):471-482. PubMed ID: 30096273
[TBL] [Abstract][Full Text] [Related]
27. Incidence of, phenotypes of and survival from small bowel cancer in Denmark, 1994-2010: a population-based study.
Bojesen RD; Andersson M; Riis LB; Nielsen OH; Jess T
J Gastroenterol; 2016 Sep; 51(9):891-9. PubMed ID: 26847562
[TBL] [Abstract][Full Text] [Related]
28. Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance.
Mosquera C; Koutlas NJ; Fitzgerald TL
Eur J Surg Oncol; 2016 Oct; 42(10):1471-7. PubMed ID: 27528467
[TBL] [Abstract][Full Text] [Related]
29. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Lee MR; Harris C; Baeg KJ; Aronson A; Wisnivesky JP; Kim MK
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2212-2217.e1. PubMed ID: 30580091
[TBL] [Abstract][Full Text] [Related]
30. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
[TBL] [Abstract][Full Text] [Related]
31. Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.
Neklason DW; VanDerslice J; Curtin K; Cannon-Albright LA
Endocr Relat Cancer; 2016 Feb; 23(2):93-100. PubMed ID: 26604321
[TBL] [Abstract][Full Text] [Related]
32. Gastroenteropancreatic neuroendocrine tumors in Iceland: a population-based study.
Gudmundsdottir H; Möller PH; Jonasson JG; Björnsson ES
Scand J Gastroenterol; 2019 Jan; 54(1):69-75. PubMed ID: 30638086
[TBL] [Abstract][Full Text] [Related]
33. Small intestinal neuroendocrine tumors: prognostic factors and survival.
Bergestuen DS; Aabakken L; Holm K; Vatn M; Thiis-Evensen E
Scand J Gastroenterol; 2009; 44(9):1084-91. PubMed ID: 19572232
[TBL] [Abstract][Full Text] [Related]
34. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
Niederle MB; Hackl M; Kaserer K; Niederle B
Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
[TBL] [Abstract][Full Text] [Related]
35. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M
Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541
[TBL] [Abstract][Full Text] [Related]
36. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.
Ptasnuka M; Ozolins A; Narbuts Z; Truskovs A; Sperga M; Plaudis H
World J Surg; 2020 Feb; 44(2):585-593. PubMed ID: 31605174
[TBL] [Abstract][Full Text] [Related]
38. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum.
Boudreaux JP; Klimstra DS; Hassan MM; Woltering EA; Jensen RT; Goldsmith SJ; Nutting C; Bushnell DL; Caplin ME; Yao JC;
Pancreas; 2010 Aug; 39(6):753-66. PubMed ID: 20664473
[TBL] [Abstract][Full Text] [Related]
39. Unexpected Finding of a Small Intestinal Neuroendocrine Tumor: A Case Report and Literature Review.
Patanè E; Sgardello SD; Guendil B; Fournier I; Abbassi Z
Am J Case Rep; 2020 Jan; 21():e917759. PubMed ID: 31988272
[TBL] [Abstract][Full Text] [Related]
40. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum.
Blažević A; Hofland J; Hofland LJ; Feelders RA; de Herder WW
Endocr Relat Cancer; 2018 Mar; 25(3):R115-R130. PubMed ID: 29233841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
